ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maryland » Rheumatology

Top Rheumatology Prescribers in Maryland

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RIDA FRAYHA M.D.

Rheumatology

12,752

$1.08M

337
310 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 27%

$84
Average prescription price

Avg: $138

ANURADHA REDDY M.D

Rheumatology

12,304

$830K

447
271 are 65+

21%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$67
Average prescription price

Avg: $138

MICHAEL CROUCH M.D.

Rheumatology

6,791

$505K

588
425 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$74
Average prescription price

Avg: $138

JAMAL MIKDASHI M.D.

Rheumatology

3,533

$386K

229
145 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 27%

$109
Average prescription price

Avg: $138

YINGXUE ZHANG M.D.

Rheumatology

3,496

$255K

429
289 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $138

PETER HOLT M.D.

Rheumatology

2,572

$338K

245
204 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$131
Average prescription price

Avg: $138

HOWARD HAUPTMAN M.D.

Rheumatology

2,459

$524K

384
286 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 27%

$213
Average prescription price

Avg: $138

JEROME SCHNAPP M.D.

Rheumatology

2,274

$204K

172
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 27%

$90
Average prescription price

Avg: $138

EDMUND MACLAUGHLIN MD

Rheumatology

2,252

$477K

359
265 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 27%

$212
Average prescription price

Avg: $138

WILLIAM YAP M.D.

Rheumatology

2,229

$659K

257
202 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 27%

$295
Average prescription price

Avg: $138

JONATHAN ADELSON M.D.

Rheumatology

2,152

$179K

215
126 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

30%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 27%

$83
Average prescription price

Avg: $138

DANIEL ELBOGDADI MD

Rheumatology

2,149

$162K

240
171 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 27%

$76
Average prescription price

Avg: $138

JOHN MEYERHOFF M.D.

Rheumatology

2,022

$296K

179
104 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$147
Average prescription price

Avg: $138

PAUL GERTLER M.D.

Rheumatology

1,943

$184K

218
175 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 27%

$95
Average prescription price

Avg: $138

EVAN SIEGEL M.D.

Rheumatology

1,775

$273K

162
140 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 27%

$154
Average prescription price

Avg: $138

MICHAEL BARTH M.D.

Rheumatology

1,746

$156K

224
195 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 27%

$90
Average prescription price

Avg: $138

NATHAN WEI M.D.

Rheumatology

1,741

$373K

177
145 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$214
Average prescription price

Avg: $138

MARLYN LORENZO MD

Rheumatology

1,736

$310K

229
142 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 27%

$179
Average prescription price

Avg: $138

OLIVER LAWLESS MD

Rheumatology

1,729

$214K

64
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$124
Average prescription price

Avg: $138

JAMES BELLOR M.D.

Rheumatology

1,675

$311K

149
106 are 65+

17%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 6%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$186
Average prescription price

Avg: $138

STEVEN KLEIN MD

Rheumatology

1,619

$334K

330
236 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 27%

$206
Average prescription price

Avg: $138

MICHELLE PETRI M.D.

Rheumatology

1,598

$137K

154
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 27%

$86
Average prescription price

Avg: $138

JAMES ROBERSON M.D.

Rheumatology

1,437

$163K

192
116 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

30%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$113
Average prescription price

Avg: $138

KUNDAN KARKHANIS MD

Rheumatology

1,428

$203K

144
82 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 27%

$142
Average prescription price

Avg: $138

FREDRICK WIGLEY M.D.

Rheumatology

1,416

$290K

130
69 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$205
Average prescription price

Avg: $138

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank